![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, March 11, 2019 6:27:27 AM
“The contribution of the $2 million per week increased guidance for allergy testing services billing to revenues and earnings will be detailed in the company’s upcoming quarterly and annual FY2019 financial filings.”
Since today’s update occurred in 2019, it is stated that this info will be in the required reports for this year. By meeting required due dates for Quarterly and FY2019 Annual Reporting, this assumes the company will be current. Looking this month for FY14-18 fins to be current, to set them on the course for normal 2019 financial reporting. Great news!!
FEATURED Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM